Pharmaceutical companies around the world are facing pressure from a number of sides: On the one hand it is getting increasingly complex to meet regulatory requirements by the government and the healthcare industry. Other than that generics manufacturers are becoming a serious threat demanding faster time to market more than ever.
Rockwell Automation published a white paper addressing the evolution and recent issues of the global pharmaceutical industry. They demonstrate why setting up MES or EBR systems can be crucial to overcome the above-named challenges and ensure long-term success in the industry.
EBR system benefits:
- EBR systems cut in batch-review cycle times, investigations, manual entries and entry mistakes.
- Pre-validated recipe building blocks available in advanced EBR systems can be re-used to achieve shorter deployment times.
- Automated data collection and human error risk reduction lead to inventory savings and less waste.